Our 2017 Annual Meeting of Stockholders was held on Wednesday, May 10, 2017, at 9:00 a.m., at the CVS Health Customer Support Center located at One CVS Drive in Woonsocket, Rhode Island. We sincerely thank those of you who were able to attend, in person or by proxy, and we thank you for your votes.  We look forward to seeing you in 2018.

We remain confident that our leadership across the pharmacy spectrum will allow us to continue to drive superior value for our health care partners and our shareholders. Thank you for investing in CVS Health.


David W. Dorman
Chairman of the Board


Larry J. Merlo
President and Chief Executive Officer

Meeting Information

May 10, 2017, 9:00 A.M.

CVS Health Corporation
Customer Support Center
One CVS Drive
Woonsocket, Rhode Island 02895

iconDownload Map

iconDownload Calendar

Voting Items

Item Board Recommendation Reason(s) for Board Recommendation Further Information
1 — Elect 12 director nominees in the proxy statement Each director nominee
APPROVED
Our nominees are seasoned leaders who bring a mix of skills and qualifications to the Board pages 10-19
2 — Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for fiscal 2017 APPROVED Based on its recent evaluation, our Audit Committee believes that the retention of Ernst & Young is in the best interests of the Company and its stockholders page 30
3 — Approve, on a non-binding basis, the Company’s executive compensation as disclosed in the proxy statement APPROVED Our executive compensation program reflects our unwavering commitment to paying for performance and reflects feedback received from stockholder outreach pages 32-33
4 — Recommend, by a non-binding vote, the frequency of future advisory votes Company's executive compensation Annual vote
APPROVED
We believe that an annual vote on our executive compensation program provides us with valuable and actionable feedback from our stockholders page 33
5 — Approve the Company's 2017 Incentive Compensation Plan (ICP) APPROVED Our ICP is an important tool to attract and retain quality executives and employees pages 67-71
6 – Stockholder proposal requesting a a reduction in the ownership threshold required for stockholders to call a special meeting of stockholders APPROVED The Board believes that the current ownership threshold of 25% of stockholders needed to call a special meeting is appropriate; however, it will take the voting results into account and will take action as it sees fit  
7 – Stockholder proposal requesting a report on the Company’s executive pay NOT APPROVED    
8 – Stockholder proposal requesting a report on renewable energy targets WITHDRAWN    

Our 2016 Annual Meeting of Stockholders will be held on Thursday, May 19, 2016, at 9:00 a.m., at the CVS Health Customer Support Center located at One CVS Drive in Woonsocket, Rhode Island. We invite you to attend, and ask you to please vote at your earliest convenience, whether or not you plan to attend. Your vote is important. We remain confident that our leadership across the pharmacy spectrum will allow us to continue to drive superior value for our health care partners and our shareholders. Thank you for investing in CVS Health.


David W. Dorman
Chairman of the Board


Larry J. Merlo
President and Chief Executive Officer

Meeting Information

May 19, 2016; 9:00 a.m.
CVS Health Corporation
Customer Support Center
One CVS Drive
Woonsocket, Rhode Island 02895

iconDownload Map

iconDownload Calendar

Voting Items

Item Board Recommendation Reason(s) for Board Recommendation Further Information (page)
1 — Elect 11 directors named in the proxy statement FOR each director nominee Our nominees are seasoned leaders who bring a mix of skills and qualifications to the Board 11
2 — Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for fiscal 2016 FOR Based on its recent evaluation, our Audit Committee believes that the retention of Ernst & Young is in the best interests of the Company and its stockholders 31
3 — Approve, on a non-binding basis, the Company’s executive compensation as disclosed in the proxy statement FOR Our executive compensation program reflects our unwavering commitment to paying for performance and reflects feedback received from stockholder outreach 33
4 — Stockholder proposal regarding alignment of corporate values and political contributions AGAINST See the Board’s statement of opposition AGAINST this stockholder proposal 64
5 — Stockholder proposal regarding a report on executive pay AGAINST See the Board’s statement of opposition AGAINST this stockholder proposal 66